TY - JOUR
T1 - Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.
JO - Health technology assessment (Winchester, England)
UR - http://eprints.whiterose.ac.uk/43321/
PY - 2010/10/01
AU - Whyte S
AU - Pandor A
AU - Stevenson M
AU - Rees A
ED -
DO - DOI: 10.3310/hta14suppl2/07
VL - 14
IS - Suppl. 2
SP - 47
EP - 53
Y2 - 2025/07/26
ER -